Sign in

You're signed outSign in or to get full access.

NC

NVE CORP /NEW/ (NVEC)·Q4 2025 Earnings Summary

Executive Summary

  • Q4 FY2025 revenue was $7.27M, up 3% year over year and up 44% sequentially; diluted EPS was $0.80, up 2% YoY, with gross margin at 79% and operating/net margins of 58%/54% for the quarter .
  • Mix and channel normalization drove better margins: management cited a “more profitable product mix” and a larger share of direct (vs. distributor) sales as drivers of gross margin increasing to 79% from 76% YoY .
  • The Board declared a $1.00 quarterly cash dividend (payable May 30, 2025), and management outlined a step-up in FY2026 capex to $2–$3M to expand capacity and enable more wafer-level chip-scale offerings .
  • No Wall Street consensus from S&P Global was available for EPS or revenue for Q4 FY2025; comparisons to estimates are not applicable. Values retrieved from S&P Global.
  • Likely stock catalysts: sharp sequential reacceleration (44% q/q), margin quality, and capacity expansion plans; watch for sustainability of product demand and timing of capex returns .

What Went Well and What Went Wrong

What Went Well

  • Sequential snapback with quality mix: revenue +44% q/q, aided by a more profitable mix and higher direct sales; gross margin rose to 79% (from 76% YoY), supporting 58% operating and 54% net margins in the quarter .
  • New products and demand signals: management noted “interest in our new products” and launched advanced omnidirectional magnetic switch sensors with better data and rugged operation; trade show presence (Sensor+Test and Sensors Converge) aims to convert interest to future sales .
  • Strategic resilience to tariffs: in-house spintronics fabrication, ample raw material/WIP inventories, and country-of-origin rules limit tariff exposure and may create competitive opportunities versus U.S. peers .

Quote: “We’re pleased to report year-over-year and sequential revenue and earnings growth for the quarter.” — CEO Daniel A. Baker .

What Went Wrong

  • Full-year declines reflect earlier softness: FY2025 revenue fell 13% to $25.9M and product sales declined 16% despite a 112% increase in contract R&D; FY net income fell 12% to $15.1M ($3.11 diluted EPS) amid industry headwinds .
  • Higher R&D spend pressured opex: quarterly opex rose 17% YoY driven by +28% R&D for new product development; management is leaning into R&D to drive future growth .
  • Prior-quarter weakness underscores volatility: Q3 FY2025 revenue declined 25% YoY to $5.06M and EPS fell to $0.63 as product sales were down 22% and contract R&D -74% YoY .

Financial Results

Headline P&L vs prior year and prior quarter

MetricQ4 2024Q3 2025Q4 2025
Revenue ($USD Millions)$7.083 $5.063 $7.270
Gross Profit ($USD Millions)$5.345 $4.265 $5.754
Income from Operations ($USD Millions)$4.060 $2.961 $4.249
Net Income ($USD Millions)$3.813 $3.048 $3.892
Diluted EPS ($)$0.79 $0.63 $0.80

Notes: Management highlighted Q4 gross margin of 79% (up from 76% YoY), operating margin 58%, pretax margin 65%, and net margin 54% .

Revenue mix (segment detail)

MetricQ4 2024Q3 2025Q4 2025
Product Sales ($USD Millions)$7.035 $4.960 $6.951
Contract R&D ($USD Millions)$0.048 $0.103 $0.318
Total Revenue ($USD Millions)$7.083 $5.063 $7.270

Operating expenses

MetricQ4 2024Q3 2025Q4 2025
Research & Development ($USD Millions)$0.811 $0.870 $1.040
SG&A ($USD Millions)$0.474 $0.435 $0.466
Total Operating Expenses ($USD Millions)$1.285 $1.304 $1.506

Estimates vs Actuals (S&P Global)

  • S&P Global consensus for Q4 FY2025 EPS and revenue was not available; comparisons to estimates are not applicable. Values retrieved from S&P Global.

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Dividend per shareNext payment (May 30, 2025)$1.00 (ongoing quarterly) $1.00 declared, payable May 30, 2025 Maintained
CapexFY2026Not previously specified$2–$3M planned (cluster arriving in September quarter) New/Updated
Revenue/MarginsNear-termNot providedNot provided

Earnings Call Themes & Trends

TopicPrevious Mentions (Q2 FY2025, Q3 FY2025)Current Period (Q4 FY2025)Trend
Industry demand/Channel“Solid earnings… despite a slow industry recovery” (Q2) ; “solid earnings… despite challenging industry conditions” (Q3) Sequential +44% revenue as channel replenishes; high-quality revenue mix Improving
Gross margin driversNot specifically quantified in Q2/Q3 releasesMix and more direct sales lifted GM to 79% (vs. 76% YoY) Positive mix shift
New products/R&DNew product development investment rising (implied by opex) Multiple launches (omnidirectional magnetic sensors; wafer-level chip-scale); R&D at 14% of revenue (FY) Accelerating innovation
Capacity/CapexNo prior capex guidance in releases$2–$3M FY2026 capex; equipment cluster arrives next quarter; expansion/infrastructure complete Capacity build
Tariffs/Supply chainNot discussed in prior two releasesLimited exposure due to fabrication model and origin rules; ample raw/WIP inventories as buffer Manageable risk
Key customersNot highlighted in releasesExtended supplier partnering agreement with Abbott (8-K referenced) Relationship deepening

Management Commentary

  • Strategic positioning on tariffs and supply chain: “We’re uniquely well situated with respect to tariffs… ample raw material and work-in-process inventories… the great majority of our exports… are exempt from retaliatory tariffs.” — CEO Daniel A. Baker .
  • Capacity expansion underway: “We completed our planned expansion… deployed [new] machines… a several million dollar machine is scheduled to arrive next quarter.” .
  • Product leadership: “We launched the world’s most advanced magnetic switch sensors… more reliable data, more information and rugged operation.” .
  • Margin commentary: “Gross margin increased to 79% from 76% due to a more profitable product mix and a larger portion of direct rather than distributor sales.” — Daniel Nelson, PFO .
  • Dividend continuity: $1.00 per share quarterly dividend declared for payment May 30, 2025 .

Q&A Highlights

  • Channel normalization vs. new business: “It was a combination of both… customers are replenishing… and we’ve seen new business and significant interest in our new products.” .
  • New products/TAM expansion: Focused on medical devices and industrial control/IIoT; omnidirectional magnetic sensors enable flexibility in advanced robotics/mechatronics; strategy is to lead on size, sensitivity, power efficiency .
  • Isolator performance: Interfaces for wide band-gap FETs with “highest isolation voltage in the industry up to 7 kilovolts” and best-in-industry CMTI, enabling faster high-voltage switching .
  • Capex returns: Confidence based on prototype/sample feedback; expected to “open significant new markets,” with equipment cluster delivery in the September quarter .

Estimates Context

  • S&P Global consensus for Q4 FY2025 EPS and revenue was not available; therefore, no beat/miss determination versus Street. Values retrieved from S&P Global.
  • Implication: With no formal consensus and sparse coverage, revisions risk is limited; investor focus should center on sequential recovery, mix, and capex-led capacity expansion .

Key Takeaways for Investors

  • Sequential inflection with quality mix: +44% q/q revenue and higher direct mix expanded margins (GM 79%, OM 58%, NM 54%), supporting earnings leverage even at modest revenue levels .
  • Product cycle momentum: Multiple sensor launches and strong isolator specs (up to 7 kV isolation, industry-best CMTI) reinforce differentiation in medical/industrial end-markets .
  • Capacity as growth enabler: $2–$3M FY2026 capex (equipment arriving next quarter) should expand capability and support wafer-level chip-scale offerings .
  • Dividend durability: $1.00 quarterly dividend maintained; cash/marketable securities and high margins support ongoing returns of capital .
  • Risk checks: Earlier-year softness (FY revenue -13%, product sales -16%) underscores demand volatility; R&D and SG&A investments elevate opex near term as the company pursues growth .
  • Tariff insulation: Fabrication model, origin rules, and inventory strategy mitigate tariff risks and could offer competitive advantages versus U.S. peers with higher exposure .
  • Watch next quarter: Conversion of pipeline/trade show interest to orders, progress on equipment installation/yields, and sustainability of channel replenishment are the near-term drivers .